A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
A legfontosabb adatok
- Hol
- Boston, Bowling Green, Camp Hill, Charleston, Charlotte, Cleveland, Columbia, Dallas, Durham, Farmington, Fountain Valley, Fremont, Frisco, Hialeah, Indianapolis, Los Angeles, Louisville, Marriottsville, Mayfield Heights, Miami, Milwaukee, Murfreesboro, Nashville, North Little Rock, Omaha, Phoenix, Portsmouth, Rogers, Sandy Springs, Santa Monica, Skokie, South Jordan, Spokane, St Louis, Sugarloaf, Tampa és Troy (Egyesült Államok)Mind a 42 helyszín megnézése
- Fázis
- 2. fázis
Helyszínek itt: Egyesült Államok
- Beth Israel Deaconess Medical CenterBoston, Egyesült ÁllamokNo longer taking part
- Equity Medical Bowling GreenBowling Green, Egyesült ÁllamokNo longer taking part
- DermDox Centers for DermatologyCamp Hill, Egyesült ÁllamokNo longer taking part
- Medical University of South CarolinaCharleston, Egyesült ÁllamokNo longer taking part
- Darst DermatologyCharlotte, Egyesült ÁllamokNo longer taking part
- Dermatology Specialists of CharlotteCharlotte, Egyesült ÁllamokNo longer taking part
- University Hospitals Cleveland Medical Center*Cleveland, Egyesült ÁllamokNo longer taking part
- Columbia Dermatology & AestheticsColumbia, Egyesült ÁllamokNo longer taking part
- Modern Research AssociatesDallas, Egyesült ÁllamokNo longer taking part
- Duke University Medical CenterDurham, Egyesült ÁllamokNo longer taking part
- University of ConnecticutFarmington, Egyesült ÁllamokNo longer taking part
- First Oc Dermatology Research IncFountain Valley, Egyesült ÁllamokNo longer taking part
- Center For Dermatology Clinical Research, Inc.Fremont, Egyesült ÁllamokNo longer taking part
- North Texas Clinical ResearchFrisco, Egyesült ÁllamokNo longer taking part
- Direct Helpers Research CenterHialeah, Egyesült ÁllamokNo longer taking part
- Dawes Fretzin Clinical Research Group, LLCIndianapolis, Egyesült ÁllamokNo longer taking part
- Dermatology Research AssociatesLos Angeles, Egyesült ÁllamokNo longer taking part
- Derm Research LLCLouisville, Egyesült ÁllamokNo longer taking part
- Care Access-MarriottsvilleMarriottsville, Egyesült ÁllamokNo longer taking part
- Apex Clinical Research CenterMayfield Heights, Egyesült ÁllamokNo longer taking part
- Skin Research of South FloridaMiami, Egyesült ÁllamokNo longer taking part
- University of MiamiMiami, Egyesült ÁllamokNo longer taking part
- Medical College of WisconsinMilwaukee, Egyesült ÁllamokNo longer taking part
- International Clinical Research - Tennessee (IC Research)Murfreesboro, Egyesült ÁllamokNo longer taking part
- Advanced Research ExpertsNashville, Egyesült ÁllamokNo longer taking part
- Arkansas Research Trials, LLCNorth Little Rock, Egyesült ÁllamokNo longer taking part
- Skin Specialists, P.COmaha, Egyesült ÁllamokNo longer taking part
- Medical Dermatology SpecialistsPhoenix, Egyesült ÁllamokNo longer taking part
- Saguaro Dermatology Associates, LLC - Probity - PPDSPhoenix, Egyesült ÁllamokNo longer taking part
- ActivMed Practices & Research, Inc.Portsmouth, Egyesült ÁllamokNo longer taking part
- Northwest Arkansas Clinical Trials CenterRogers, Egyesült ÁllamokNo longer taking part
- Advanced Medical Research, PC.Sandy Springs, Egyesült ÁllamokNo longer taking part
- Dermatology Institute and Skin Care CenterSanta Monica, Egyesült ÁllamokNo longer taking part
- NorthShore Medical Group Dermatology SkokieSkokie, Egyesült ÁllamokNo longer taking part
- Jordan Valley Dermatology CenterSouth Jordan, Egyesült ÁllamokNo longer taking part
- Dermatology Specialists of SpokaneSpokane, Egyesült ÁllamokNo longer taking part
- Washington University School of MedicineSt Louis, Egyesült ÁllamokNo longer taking part
- DermDox Dermatology CentersSugarloaf, Egyesült ÁllamokNo longer taking part
- Alliance Clinical Research of TampaTampa, Egyesült ÁllamokNo longer taking part
- ForCare Clinical ResearchTampa, Egyesült ÁllamokNo longer taking part
- Olympian Clinical ResearchTampa, Egyesült ÁllamokNo longer taking part
- Revival Research Institute - TroyTroy, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Eli Lilly and Company
- Azonosító
- NCT06046729EU 2023-505608-43-00
- A regiszteradat frissítve
- 2026. augusztus 21.
- Eredeti leírás
This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis suppurativa (HS) for further clinical development. The study will last approximately 62 weeks and may include up to 31 visits.A teljes eredeti leírásKevesebb
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis suppurativa (HS) for further clinical development. The study will last approximately 62 weeks and may include up to 31 visits.
Bevonási feltételek: Have a diagnosis of HS for at least 12 months; Have HS lesions in at least 2 distinct anatomical regions. At least 1 of the lesions must be at least Hurley Stage II or III; Have an (abscess plus inflammatory nodule) count of at least 5; Agree to use topical antiseptics daily; Had an inadequate response or intolerance to a 28-day course of oral antibiotics.
Kizáró feltételek: Have had surgical treatment for HS in the last 4 weeks before randomization; Have an active skin disease or condition, that could interfere with the assessment of HS; Have a current or recent acute, active infection; Have a history of chronic alcohol abuse, IV drug abuse, or other illicit drug abuse within 1 year before screening; Have more than 20 draining fistulae; Are immunocompromised.